Scinai Immunotherapeutics Ltd. (SCNI)
NASDAQ: SCNI · Real-Time Price · USD
0.251
-0.004 (-1.57%)
At close: Jun 26, 2026, 4:00 PM EDT
0.272
+0.021 (8.33%)
After-hours: Jun 26, 2026, 7:29 PM EDT
Scinai Immunotherapeutics Employees
Scinai Immunotherapeutics had 45 employees as of December 31, 2025. The number of employees increased by 14 or 45.16% compared to the previous year.
Employees
45
Change (1Y)
14
Growth (1Y)
45.16%
Revenue / Employee
$26,978
Profits / Employee
-$70,511
Market Cap
993.91K
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Valion Bio | 52 |
| Jaguar Health | 47 |
| Calidi Biotherapeutics | 29 |
| Virax Biolabs Group | 19 |
| Silexion Therapeutics | 14 |
| Azitra | 13 |
| Biodexa Pharmaceuticals | 11 |
| Decoy Therapeutics | 11 |
SCNI News
- 18 days ago - Scinai Reports First Quarter 2026 Financial Results and Provides Corporate Update Highlighting Expansion of CDMO Platform and Advancement of Strategic Growth Initiatives - PRNewsWire
- 5 weeks ago - Scinai Biopharma Services Appoints Eilon Elmalem as Site Head of Yavne CDMO Facility - PRNewsWire
- 6 weeks ago - Scinai Immunotherapeutics to Lead Strategic Roundtable Discussion on Oral Therapies and the Future of Biologics at the 7th Dermatology Drug Development Summit Europe - PRNewsWire
- 2 months ago - Why Is Scinai Immunotherapeutics Stock (SCNI) Up Today? - TipRanks
- 2 months ago - Why Scinai Immunotherapeutics Stock Is Skyrocketing 90% Higher Today - Benzinga
- 2 months ago - Scinai Immunotherapeutics announces $2.61M private placement - TheFly
- 2 months ago - Scinai Immunotherapeutics Announces $2.61 Million Private Placement Financing - PRNewsWire
- 2 months ago - Scinai Immunotherapeutics completes strategic reorganization - TheFly